PSP

Clinical trials for PSP explained in plain language.

Never miss a new study

Get alerted when new PSP trials appear

Sign up with your email to follow new studies for PSP, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 2 Not yet recruiting 2 Not yet finished but already full! 3 Completed 1

Can a failed ALS drug help PSP patients? new trial results are in

Disease control Completed

This completed Phase 2b/3 trial tested the drug AMX0035 in 139 people with progressive supranuclear palsy (PSP), a rare brain disease that causes problems with balance, movement, and thinking. The study compared the drug to a placebo to see if it could slow the disease. The resul…

Matched conditions: PSP

Phase: PHASE2, PHASE3 • Sponsor: Amylyx Pharmaceuticals Inc. • Aim: Disease control

Last updated Jun 27, 2026 12:26 UTC

PSP

Get alerted when new PSP trials appear

Can a failed ALS drug help PSP patients? new trial results are in